Gerges, Amgad and Canning, Una (2026) AI-assisted prioritisation of novel SSTR2 ligands for high-risk stage 4 neuroblastoma: integrating generative analogue design, deep-learning ADMET prediction and retrosynthetic planning. AI Chemistry, 1(4) (16). pp. 1-34. ISSN 3042-6723
Gerges, Amgad and Canning, Una (2026) Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways. Exploration of Drug Science, 4: 1008142. pp. 1-2. ISSN 2836-7677
Gerges, Amgad and Canning, Una (2025) High-risk neuroblastoma stage 4 (NBS4): developing a medicinal chemistry multi-target drug approach. Molecules, 30(10) (2211). pp. 1-22. ISSN 1420-3049
Gerges, Amgad and Canning, Una (2025) High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways. Exploration of Drug Science, 3 (008109). pp. 1-17. ISSN 2836-7677
Gerges, Amgad and Canning, Una (2024) Neuroblastoma and its target therapies: a medicinal chemistry review. ChemMedChem, 19 (9). pp. 1-23. ISSN 1860-7187